Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity

NCT01361217 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01361217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01361217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
June 30, 2012
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug-drug interaction, healthy volunteers